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a b s t r a c t
Heparin-binding epidermal growth factor (EGF)- like growth factor (HB-EGF) is synthesized in the ER,
transported along the exocytic pathway, and expressed on the plasmamembrane as a type I transmem-
brane protein. Upon extracellular stimulation, HB-EGF, either proHB-EGF or the shed formHB-EGF-CTF,
undergoes endocytosis and is then transported retrogradely to the ER. In this study, we showed the
essential contribution of the short cytoplasmic tail of HB-EGF (HB-EGF-cyto) to the bidirectional intra-
cellular trafﬁcking between the ER and plasma membrane and revealed several critical amino acids
residues that are responsible for internalization from the plasmamembrane and ER targeting. We sug-
gest that these anterograde and retrograde sorting signals within HB-EGF-cyto are strictly regulated by
protein modiﬁcation and conformation.
c© 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Heparin-binding epidermal growth factor (EGF)-like growth fac-
tor (HB-EGF) is a member of the EGF family. HB-EGF is expressed in
multiple tissues, and participates in a variety of normal and aberrant
processes including blastocyst implantation, wound healing, smooth
muscle cells hyperplasia, and tumor growth [reviewed in 1]. The
membrane-anchored form of HB-EGF is the receptor for diphthe-
ria toxin [2]. HB-EGF is synthesized by ER-bound ribosomes and
expressed at the cell surface as a type I transmembrane precur-
sor (proHB-EGF). The extracellular portion of proHB-EGF contains a
heparin-binding domain and a bioactive EGF-like sequence; the in-
tracellular portion (HB-EGF-cyto) consists of 24 amino acids [3,4]. The
EGF-like growth factor domain alone is sufﬁcient to elicit EGF recep-
tor (EGFR) phosphorylation via autocrine, juxtacrine, and paracrine
signaling pathways. ProHB-EGF is cleaved at the juxtamembrane site
by activated metalloproteases, yielding a soluble growth factor and aAbbreviations: TPA, phorbol ester 12-O-tetradecanoylphorbol-13-acetate; EGF, epi-
dermal growth factor; HB-EGF, heparin-binding EGF-like growth factor; EGFR, EGF
receptor; HB-EGF-cyto, cytoplasmic tail of HB-EGF; maHB-EGF-cyto, membrane an-
chored HB-EGF-cyto; CTF, carboxy-terminal fragment; NE, nuclear envelope; TCA,
trichloroacetic acid
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toplasmic segments (HB-EGF-CTF). This process, termed ectodomain
shedding, can be stimulated by various physiological and pharma-
cological agonists, including 12-O-tetradecanoylphorbol-13-acetate
(TPA) [5], calcium ionophores [6], and ligands of G protein coupled
receptors [7]. We previously showed that in addition to these well-
known signaling pathways mediated by the extracellular EGF-like
growth factor domain, themembrane-anchoredHB-EGF-cyto (maHB-
EGF-cyto), which indicates both unshed proHB-EGF and HB-EGF-CTF
(see Fig. 1(A)), migrates from the plasma membrane to the ER and
nuclear envelope (NE) [8]; there, maHB-EGF-cyto faces to the nucle-
oplasm and directly regulates gene expression [9,10]. However, the
molecular mechanism underlying the bidirectional intracellular traf-
ﬁcking of this protein between the plasmamembrane and ER remains
unknown. How is the newly synthesized proHB-EGF,which possesses
ER retrieval activity, delivered to the plasma membrane? How is the
ER retrieval activity activated in response to shedding stimuli? A ma-
jor goal of this article is thus to reveal the molecular mechanism that
regulates the intracellular sorting of maHB-EGF-cyto in opposite di-
rections. In this study, to address these questions, we used various
mutants of HB-EGF and a monoclonal antibody against HB-EGF-cyto.. Open access under CC BY-NC-ND license.
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Fig. 1. The extracellular domain is not essential for the intracellular trafﬁcking of
maHB-EGF-cyto. (A) Schematic presentation of HB-EGF processing. HB-EGF is synthe-
sized as pre-proHB-EGF by ER-bound ribosomes, and expressed at the plasma mem-
brane as proHB-EGF. ProHB-EGF is cleaved at the juxtamembrane domain, yielding
soluble HB-EGF and HB-EGF-CTF. Here we collectively refer to proteins containing the
membrane-anchored cytoplasmic tail (proHB-EGF and HB-EGF-CTF) as ‘maHB-EGF-
cyto’. SP: signal peptide and TM: transmembrane domain. (B) HT1080 cells were tran-
siently transfected with HB-EGF-V5-C (left) or HB-EGF-ΔED-V5-C (right). Cells were
treated with TPA, and then ﬁxed; intracellular localization was visualized with anti-V5
mAb. (C) HB-EGF-V5-Cwas transfected into the GalT stably expressing COS1 cells. Then
cells were stained with anti-V5 mAb. (D) HB-EGF-V5-C transfected HT1080 cells were
ﬁxed with PFA and permeabilized with Tween 20. Then cells were immunostained
with anti-V5 mAb. Right panel is an over exposed photo. (E) Schematic presentation of
an HB-EGF mutant lacking the extracellular domain (HB-EGF-ΔED-V5-C). V5-epitope
tag (indicated as V5) was inserted just downstream of the transmembrane domain,
because tagging at the C terminus interferes with the function of HB-EGF [9] and sta-
bilizes phosphorylation of maHB-EGF-cyto [14]. (F) HB-EGF-ΔED-V5-C was transiently
transfected into HT1080 cells. After TPA treatment, total cell lysate were analyzed
by immunoblotting using anti-V5 mAb. * indicates the carboxyl-terminal fragment of
HB-EGF-ΔED-V5-C. Bar, 10 μm.
Fig. 2. The cytoplasmic tail ofHB-EGF contributes to bidirectional sorting to the plasma
membrane and ER. (A) Schematic presentation of HB-EGF constructs used in this study.
The mutated amino acids are indicated in red. The sizes of expressed proteins were
veriﬁed by Western blotting using anti-V5 mAb (data not shown). (B, C) HT1080 cells
were transfected with indicated plasmids and treated with TPA, followed by ﬁxation.
Cells were stained with anti-V5 mAb. Bar, 10 μm. (For interpretation of the references
to color in this ﬁgure legend, the reader is referred to the web version of this article.)
antibodies were from Medical & Biological Laboratories. All ﬂuores-
cently labeled secondary antibodies were purchased from Jackson
ImmunoResearch. Anti-HB-EGF polyclonal antibodies (#H1)were de-
scribed in [11].2. Materials and methods
2.1. Construction of plasmids
The plasmids encoding YFP-fused HB-EGF (pEYFP-N1-HB-EGF)
and HB-EGF with the carboxyl-terminal 10 amino acids deleted were
described previously [9]. Internally V5-tagged HB-EGF (pME18S-
HB-EGF-V5-C), HB-EGF-V5-ΔC, HB-EGF-V5-K201A-ΔC, HB-EGF-V5-
K201A, and constructs encoding GFP fused to the C-terminal 10-
or 15-amino acid regions of HB-EGF-cyto (199–208 and 194–208,
respectively) were described previously [8]. HB-EGF-V5-S207D and
HB-EGF-V5-S207Awere constructedbyoligonucleotide-directedmu-
tagenesis using HB-EGF-V5-C as a template. HB-EGF-ΔED-V5-C was
constructed by overlapping PCR. All cDNA constructs were veriﬁed by
DNA sequencing.
2.2. Antibodies
Rat monoclonal antibodies against HB-EGF-cyto (mAbC and
mAbD) were raised against a synthetic peptide corresponding to HB-
EGF-cyto (185–208). The details were described in [8]. Mouse anti-
V5 mAb was purchased from Invitrogen. Rabbit anti-GFP polyclonal2.3. Cell culture, transfection and TPA treatment
HT1080 cells were grown in Eagle’s minimum essential medium
supplemented with 10% fetal calf serum and 0.1 mM non-
essential amino acids. COS cells stably expressing human β-1,4-
galactosyltransferase-GFP (GalT-GFP) [12] were grown in Dulbecco’s
modiﬁed Eagle’s medium supplemented with 10% fetal calf serum.
Transfections were performed using LipofectamineTM 2000 (Invit-
rogen). 12-O-tetradecanoylphorbol-13-acetate (TPA) was purchased
from Sigma, dissolved in DMSO as a 100 μM stock, and stored at −30
◦C. For TPA treatment, TPAwas added to the culturemedium at a ﬁnal
concentration of 100 nM and incubated for 30 min at 37 ◦C.
2.4. Immunoﬂuorescence
For Figs. 1(B,C) and 2(B,C), cells were ﬁxed with 4% formaldehyde
at RT for 20 min and permeabilized with 0.4% Triton X-100. For Fig.
1(D), cells were ﬁxed with 4% formaldehyde at RT for 20 min and
permeabilizedwith 0.1% Tween 20. For Fig. 3(B), cells were ﬁxedwith
ice-cold 10% trichloroacetic acid (TCA) at RT for 20min and permeabi-
lized with 0.4% Triton X-100 for 5 min. Cells were then blocked with
2% BSA, incubated with primary antibodies overnight at 4 ◦C, and
subsequently incubated with Cy3- or FITC-conjugated secondary an-
tibodies. Image acquisition was performed using a microscope (IX70;
Olympus) equipped with a camera (ORCA-ER; Hamamatsu).
2.5. Western blotting
Indicated plasmids were transfected into HT1080 cells. After 16
h, cells were treated with TPA and collected in SDS–PAGE sample
buffer. Total cell lysates were separated by SDS–PAGE and trans-
ferred to nitrocellulose membranes. Blots were blocked with 3% skim
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Fig. 3. A monoclonal antibody against the cytoplasmic tail of HB-EGF, mAbC, recog-
nizesmaHB-EGF-cyto only after addition of shedding stimuli. (A) Cells were transiently
transfectedwith carboxyl-terminally YFP-tagged HB-EGF. Cells were then treatedwith
TPA and analyzed by Western blotting using anti-HB-EGF-cyto pAbs (left) or mAbC
(right). To clearly separate the two HB-EGF-CTF bands, YFP-tagged HB-EGF was used
because theHB-EGF-CTFs are too small to separate clearly (calculatedmolecularweight
is around 6.5 kDa). (B) HB-EGF-V5-C transiently expressing cells were treatedwith TPA
and ﬁxed with ice-cold 10% TCA; cells were then permeabilized with 0.4% Triton X-
100 and stained with mAbC. (C) Total cell lysate expressing GFP fused to the 15 or 10
carboxyl-terminal amino acids of proHB-EGF (194–208 or 199–208, respectively) were
analyzed by immunoblotting using mAbC (right). (D) Identical quantities of the indi-
cated peptides were blotted onto nitrocellulose membrane and detected with mAbC.
milk, and then incubatedwith the primary antibody followed byHRP-
conjugated secondary antibodies.
2.6. Dot blotting
Synthetic peptide was obtained from Sigma Aldrich and dissolved
according to the manufacturer’s instructions. Each peptide solution
was applied to the nitrocellulose and dried. The nitrocellulose sheets
were washed, blocked with 3% skim milk/PBS-T, and incubated with
primary antibody followed by HRP-conjugated secondary antibody.
Detection was performed using an AEC kit (Vector Laboratories).
3. Results
3.1. The extracellular domain of HB-EGF is not essential for
intracellular trafﬁcking
In the absence of ectodomain-shedding stimuli, proHB-EGF was
predominantly localized at the plasma membrane and in the per-
inuclear regions [8] (also see Fig. 1(B,a)). The perinuclear signal is
colocalized with a medial-trans-Golgi marker, GalT (Fig. 1(C)). This
signal probably represents newly synthesized (pre)proHB-EGF be-
cause it disappeared after translation block by cycloheximide (data
not shown). Here we use the term ‘maHB-EGF-cyto’ to refer collec-
tively to proHB-EGF and HB-EGF-CTF (please see Fig. 1(A)), because
proHB-EGF as well as HB-EGF-CTF are targeted to the ER and NE (ER/
NE). In response to the shedding stimuli, maHB-EGF-cytowas relocal-
ized to the ER (Fig. 1(B,b) and (D)) as shownpreviously [8]. Here in Fig.
1(D), we used Tween 20 to permeabilize the plasma membrane and
to retain the ER meshwork structure. In order to identify the domain
responsible for the intracellular trafﬁcking of HB-EGF, we deleted the
extracellular EGF-like growth factor domain (HB-EGF-ΔED-V5-C, Fig.
1(E)). The truncated mutant produced a protein of the predicted size,
and shed after exposure to shedding stimuli (Fig. 1(F)). This mutant
was localized at the plasma membrane and Golgi apparatus in the
absence of shedding stimuli (Fig. 1(B,c)) and relocalized to the ER/NE
in response to shedding stimuli (Fig. 1(B,d)), in a manner similar to
the wild type; however, the level of accumulation at the Golgi com-
plex was slightly higher than in the wild type, possibly because of
differences in glycosylation efﬁciency. This result indicates that the
extracellular domain of proHB-EGF is not essential for intracellular
trafﬁcking in either direction, i.e., to the plasma membrane or to the
ER.
3.2. The cytoplasmic tail of proHB-EGF contributes to retrograde
trafﬁcking from the plasma membrane to the ER
Next, to investigate the roles of the cytoplasmic tail of proHB-EGF
(HB-EGF-cyto) in intracellular trafﬁcking between the plasma mem-
brane and ER, we introduced several mutations (Fig. 2(A)). HB-EGF
lacking the 5 C-terminal amino acids (HB-EGF-V5-ΔC)was retained at
the ER (Fig. 2(B,a)) because of an unintentionally generated K(X)KXX-
type ER retrieval signal [13]. This localization was not affected in the
presence of shedding stimuli (Fig. 2(B,c)). On the other hand, HB-EGF-
V5-K201A-ΔC was observed at the plasma membrane and the Golgi
apparatus, similar to the wild type (Fig. 2(B,b)), but was not relocal-
ized to the ER/NE after exposure to shedding stimuli (Fig. 2(B,d)).
Previously, we showed that K201A does not affect endocytosis [8].
Thus, these results indicate that the carboxyl-terminal 5 amino acids
are not required for plasma membrane targeting, but are indispens-
able for internalization. The carboxyl-terminal 5 amino acids contain
a conserved serine residue (S207) that is phosphorylated in response
to shedding stimuli [14]. To examine whether phosphorylation of
this residue plays a role in the regulation of maHB-EGF-cyto local-
ization, we replaced S207 with A or D (termed HB-EGF-V5-S207A or
HB-EGF-V5-S207D, respectively; Fig. 2(A)). Western blotting analysis
showed that neither mutant had an effect on ectodomain shedding
efﬁciency (data not shown). S207Awas localized at the plasmamem-
brane in the absence of shedding stimuli (Fig. 2(C,a)). However, the
efﬁciency of internalization of this mutant is less than wild type (Fig.
2(C,c)), implying that either the presence of serine at position 207 or
phosphorylation of this residue is required for the regulation of inter-
nalization but not for plasma membrane localization. In contrast, the
phosphorylation-mimic mutant, S207D was expressed at the plasma
membrane (Fig. 2(C,b)) and disappeared from the plasma membrane
after shedding stimuli (Fig. 2(C,d)) indicating the internalization in
response to shedding stimuli; however, this protein did not migrate
to the ER/NE, but rather accumulated at the intracellular vesicles
in addition to the Golgi apparatus (Figs. 2(C,d) and S1). Thus, S207
phosphorylation is not sufﬁcient for the induction of internalization
in the absence of shedding stimuli, suggesting that dephosphoryla-
tion or further modiﬁcation is required at the intracellular vesicles
prior to targeting to the ER/NE. Taken together, these results indicate
that speciﬁc residues in the cytoplasmic tail of HB-EGF contribute to
retrograde trafﬁcking from the plasma membrane to the ER.
3.3. A monoclonal antibody recognizes HB-EGF-cyto only after
exposure to shedding stimuli
The cytoplasmic tail of HB-EGF has critical functions in its intra-
cellular trafﬁcking. We thus raised monoclonal antibodies against a
synthetic peptide corresponding to HB-EGF-cyto (185–208), obtain-
ing two clones, designated mAbC and mAbD. Details of mAbD were
described previously [8]. In this paper, we analyzed the regulation
of maHB-EGF-cyto intracellular localization using mAbC. In Western
blotting analysis, anti-HB-EGF-cyto polyclonal antibodies recognized
proHB-EGF in the absence of shedding stimuli; in the presence of
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shedding stimuli, the antibody detected additional two bands corre-
sponding to HB-EGF-CTF. The upper HB-EGF-CTF band, but not the
lower band, was increased in the presence of shedding stimuli (Fig.
3(A), lanes 1 and 2); this observation could be explained by S207
phosphorylation [14]. HB-EGF-CTF could be observed even in the ab-
sence of shedding stimuli, possibly due to a basal level of shedding
activity, as the serum in the culture medium contains growth factors
that induce ectodomain shedding [15].
On the other hand, mAbC unexpectedly recognized only the TPA-
induced upper band of HB-EGF-CTF, but not full length HB-EGF, in
Western blotting (Fig. 3(A), lanes 3 and 4), even though mAbC was
raised against a synthetic peptide containing no modiﬁcation. This
observation implied the presence of an epitope-masking posttransla-
tional protein modiﬁcation(s) of proHB-EGF under steady-state con-
ditions, and the removal of this modiﬁcation after exposure to the
shedding stimuli.
In immunoﬂuorescence microscopy, anti-V5 mAb stained the
plasma membrane and the Golgi complex at steady state; after ex-
posure to shedding stimuli, the antibody stained the ER/NE (Fig. 1(B)
and (D)). In contrast, mAbC did not yield any signiﬁcant signals when
cells were ﬁxed with paraformaldehyde in the presence or absence
of shedding stimuli (data not shown). Since mAbC recognizes the
slow-migrating HB-EGF-CTF on Western blots of samples exposed to
shedding stimuli (Fig. 3(A)), we attempted to preserve the antigenic-
ity for mAbC during ﬁxation using multiple ﬁxation methods, includ-
ing methanol, ethanol, and TCA. We found that mAbC could stain
maHB-EGF-cyto when cells were ﬁxed with TCA, after exposure to
shedding stimuli but not at steady state (Fig. 3(B)). TCA effectively in-
activates soluble phosphatases, thus preserving the phosphorylation
level during sample processing for immunoﬂuorescence staining [16].
This result suggest that phosphorylation in theHB-EGF-cytomight in-
duce a conformational change and expose the epitope for mAbC; as
mentioned above, no phosphorylation or protein modiﬁcations is not
contained in the antigen peptide.
3.4. Amino acids 199–208 are required for recognition by mAbC
To identify the epitope of mAbC, we fused GFP with the carboxyl-
terminal 10 or 15 amino acids of HB-EGF-cyto (residues 199–208 or
194–208, respectively), expressed these constructs in HT1080 cells,
and subjected cell lysates to Western blotting (Fig. 3(C)). mAbC rec-
ognized both constructs, indicating that the epitope of mAbC resides
in the amino acids 199–208. Next, to determine the exact epitope
recognized by mAbC, we subjected a series of peptides derived from
amino acids 194–208 to dot blotting. However, removal of even a sin-
gle residue (H208 or K199) from either end of the carboxyl-terminal
10 amino acids almost completely abolished reactivity with mAbC
(Fig. 3(D)). Therefore, we concluded that the entire carboxyl-terminal
10-amino acid region (residues 199–208) is required for recognition
by mAbC.
4. Discussion
HB-EGF shows bidirectional intracellular trafﬁcking, anterograde
and retrograde transport between the plasma membrane and ER,
and is able to localized to ﬁve different subcellular localizations, the
plasma membrane, Golgi apparatus, ER, nuclear envelope, and perin-
uclear vesicles; the latter are not further speciﬁed. This study revealed
two main ﬁndings; essential contribution of cytoplasmic tail to the
bidirectional intracellular trafﬁcking of HB-EGF and critical amino
acids residues that are responsible for retrograde sorting from the
plasma membrane to the ER.
Retrograde sorting acts on cargomolecules targeted to endosomes
from the plasma membrane. These cargo molecules are then trans-
ported to the trans-Golgi network (TGN), Golgimembrane, or in some
cases ER via retrograde route [17–19]. However retrograde sorting
route from the plasma membrane to the ER has to date only been
well characterized for some of the toxin [20]. Therefore it is to be
addressed that we ﬁrst revealed several critical amino acid residues
that are responsible for internalization from the plasma membrane
and ER.
4.1. A model for anterograde transport from the ER to plasma
membrane
Based on our results described here and our previous observa-
tions (summarized in Fig. 4(A)), we propose a model for the intra-
cellular trafﬁcking of maHB-EGF-cyto (Fig. 4(B)). Amino acids 185–
198 of maHB-EGF-cyto are capable of directing a reporter protein to
the ER and NE [8]; nevertheless, the newly synthesized proHB-EGF
is sorted to the plasma membrane. This indicates that ER retrieval/
retention activity is inactivated when proHB-EGF is synthesized in
the ER, probably by protein modiﬁcation, steric masking by a part-
ner subunit [21,22], or a conformational change. The exact molecular
mechanism for the inactivation of HB-EGF-cyto ER targeting activity
(185–198) remains unknown; however, our Western blotting exper-
iment (Fig. 3(A)), in which mAbC could not detect proHB-EGF, im-
plies that epitope-masking posttranslational protein modiﬁcation(s)
are present in the epitope domain (199–208) of newly synthesized
proHB-EGF. The epitope domain contains amino acids residues such
as K199, K201, and T205 which could have posttranslational modiﬁ-
cations such as methylation, acetylation, or phosphorylation. Shed-
ding stimuli increase mAbC accessibility to the epitope region (Fig.
3(A) and (B)) and simultaneously activate ER retrieval activity. Thus
one possible model that ﬁts the existing data is that during or just
after protein translation, a protein modiﬁcation occurs in mAbC epi-
tope region (199–208) that suppresses ER retention/retrieval activity
(185–198) via conformational change. With ER targeting blocked, the
maHB-EGF-cyto protein is instead targeted to the plasma membrane
(Fig. 4(B, , )).
4.2. A model for the internalization from the plasma membrane and
retrograde transport to the ER
Our mutagenesis analysis showed that the carboxyl-terminal 5
amino acids (203–208), and especially phosphorylation of S207, are
indispensable for internalization after exposure to shedding stim-
uli (Fig. 2). In addition, the S207D and K201A mutant accumulated
at a perinuclear organelle after exposure to shedding stimuli (Figs.
2(C) and S1 and [8], respectively). Moreover, the phosphorylation at
S207 [14] may be essential for the recognition of HB-EGF-cyto by
mAbC in immunoﬂuorescence microscopy. Based on these observa-
tions, we speculate that in response to shedding stimuli, two events
may occur at the same time, resulting in the internalization and ac-
tivation of ER targeting (Fig. 4(B, , )): ﬁrst, an epitope-exposing
conformation change is induced by S207 phosphorylation ( ); sec-
ond, epitopemasking posttranslationalmodiﬁcation ( ) is concomi-
tantly removed. Neither the precise timing nor the location of these
reactions is known. The ﬁrst event could explain the unstable confor-
mation of HB-EGF, as observed in immunoﬂuorescence microscopy
(Fig. 2(B)); the second event may explain the recognition of the HB-
EGF-cyto epitope by mAbC only after shedding stimuli exposure, as
observed in Western blotting (Fig. 2(A)). The results obtained with
the S207D mutant indicate that S207 phosphorylation is not sufﬁ-
cient for the induction of internalization in the absence of shedding
stimuli (Fig. 2(C)), supporting the idea that two events are required
and suggesting some function(s) for S207 in the ultimate localiza-
tion of the protein (ER, plasma membrane, or perinuclear vesicles).
In this regard, it is noteworthy that a chimeric protein containing
the carboxyl-terminal 10 amino acids (199–208) accumulates at the
perinuclear structure [8], whereas perinuclear targeting ability is also
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Fig. 4. A working model for the intracellular trafﬁcking of maHB-EGF-cyto and its
localization. (A) Summary of constructs used in mutagenesis analysis and their be-
havior with respect to plasma membrane targeting, internalization, and ER targeting.
Functional domains within the cytoplasmic tail involved in intracellular trafﬁcking
are in green; the region required for mAbC detection is in red. (B) A model in which
post-translational modiﬁcation regulates intracellular trafﬁcking of HB-EGF. Since the
extracellular domain of HB-EGF is not essential for intracellular trafﬁcking (Fig. 1), only
HB-EGF-cyto is shown (orange bar). Pre-proHB-EGF is synthesized by ER-bound
ribosomes. Epitope masking (199–208) occurs during or just after protein synthe-
sis Fig. 3(A), and suppresses the ER retrieval activity (185–198) via a conformation
change. In this situation, at steady state, proHB-EGF targets to the plasma mem-
brane. Internalization requires S207 phosphorylation Fig. 2(C). Accessibility
of the epitope domain to mAbC in immunoﬂuorescence microscopy Fig. 3(B) suggests
that unstable protein modiﬁcation(s) such as phosphorylation occur after exposure to
shedding stimuli, concomitant with the removal of the epitope-masking protein mod-
iﬁcation Fig. 3(A), resulting in activation of ER retrieval activity. (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version
of this article.)
inactivated in proHB-EGF at steady state, consistentwith the epitope-
masking protein modiﬁcation invoked in our model (Fig. 4(B, )).
S207D accumulated intracellular vesicles might be recycling endo-
somes, since the NE targeting of maHB-EGF-cyto utilizes the Rab11
dependent retrograde membrane trafﬁcking pathway [8]. Here we
used TPA as a shedding stimulus. Other shedding stimuli, such as
bEGF or EGF also induces NE localization of maHB-EGF-cyto [8], thus
the responseofmaHB-EGF-cyto to each shedding stimulusmighthave
its own mechanism. Further studies will be necessary to determine
the exact protein modiﬁcations and conformation of this protein. The
results reported here, however, show that the cytoplasmic tail of HB-
EGF contains sorting signals involved in trafﬁcking a single protein in
opposite directions; these signals are likely to be strictly regulated by
protein modiﬁcation and conformation.
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